Neurocrine Biosciences Inc. (NBIX)
NASDAQ · Healthcare
Neurocrine Biosciences Inc. Gross Margin 2009–2025
Current and historical gross margin for Neurocrine Biosciences Inc. (NBIX) over the last 10 years. The current gross profit margin for Neurocrine Biosciences Inc. as of December 31, 2025 is 98.18%.
From: 12/31/2009To: 12/31/2025
Revenue
Gross Profit
Gross Margin
Neurocrine Biosciences Inc. Gross Margin — FAQ
Neurocrine Biosciences Inc. (NBIX) gross margin over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Neurocrine Biosciences Inc.'s gross margin?
Neurocrine Biosciences Inc. (NBIX) reported gross margin of 98.2% for fiscal 2025.
Where can I see NBIX's gross margin history?
The chart and table above show Neurocrine Biosciences Inc.'s gross margin by year and by quarter, including the growth rate.